相关实验视频
Updated: Mar 11, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.4K
提高对高血压患者的DASH饮食知识:饮食教育干预
11Directorate of Health of Nineveh, Center of Rehabilitation of Handicap in Mosul, Iraq.
Georgian medical news
|March 10, 2026
概括
健康教育显著提高了伊拉克高血压患者对DASH (停止高血压的饮食方法) 饮食的了解. 这种干预对于促进生活方式的改变和高血压管理的自我管理至关重要.
科学领域:
- 公共卫生 公共卫生
- 营养科学 营养科学
- 卫生教育卫生教育教育
背景情况:
- 高血压是一个重大的全球健康挑战,特别是在资源有限的国家.
- 饮食干预措施,如DASH (停止高血压的饮食方法) 饮食,对于血压管理至关重要.
- 改变生活方式对于控制高血压至关重要.
研究的目的:
- 评估健康教育对高血压患者对DASH饮食的理解的影响.
- 评估伊拉克摩苏尔市饮食教育计划的有效性.
主要方法:
- 采用了准实验性,测试前和测试后的设计.
- 50名高血压患者参与了这项研究.
- 在教育干预之前和之后,通过问卷收集数据.
主要成果:
- 干预后观察到关于DASH饮食的知识得分显著改善 (p<0.001).
- 干预前,88.0%的参与者知识不佳;干预后,66.0%的人获得了良好的知识.
- 平均知识分数从30.5±13.77大幅增加到71.5±14.25.
结论:
- 饮食教育有效地提高了参与者对DASH饮食的知识.
- 将健康教育纳入日常护理可以促进高血压患者的生活方式的改变.
- 这些项目支持高血压患者的自我管理策略.
相关概念视频
Hypertension IV: Drug Therapy and Lifestyle Modifications
800
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
800
Hypertension V: Nursing Management
584
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
584
Atherosclerosis III: Management
541
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
541
Hypertension III: Clinical Manifestations and Diagnostic Studies
690
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
690
Hypertension I: Introduction
1.1K
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
1.1K
Hypertension II: Pathophysiology
1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
